Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)
NCT03636100 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2021-10-19
Summary
Determine whether the presence of acetylcholine in the systemic circulation, correlates with the hypotensive response observed during the thaw phase of cryoballoon ablation.
Conditions
Interventions
- DEVICE
-
Cryoballoon ablation
Cryoballoon ablation using standard equipment and techniques
Sponsors & Collaborators
-
Saint Luke's Health System
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-15
- Primary Completion
- 2019-10-11
- Completion
- 2019-10-11
Countries
- United States
Study Locations
More Related Trials
-
Reevaluation Of Systemic Early Neuromuscular Blockade
NCT02509078 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
NCT05993390 ·Status: RECRUITING ·Phase: NA
-
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT01571297 ·Status: COMPLETED ·Phase: PHASE2
-
Physiologic Effects of Steroids in Cardiac Arrest
NCT02790788 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
NCT02891837 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Effects of Propylene Glycol/Glycerol Intake on Blood Parameters
NCT03404011 ·Status: COMPLETED ·Phase: NA
-
Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study
NCT04706832 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
NCT04609943 ·Status: TERMINATED ·Phase: PHASE1
-
Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis
NCT00432835 ·Status: COMPLETED ·Phase: PHASE3
-
Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients
NCT03168308 ·Status: COMPLETED ·Phase: PHASE4
-
Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis
NCT02164591 ·Status: TERMINATED
-
Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)
NCT01573715 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy Study of Acthar in Subjects With ARDS
NCT02113735 ·Status: WITHDRAWN ·Phase: PHASE2
-
Sugammadex as Rescue Therapy
NCT05661409 ·Status: COMPLETED ·Phase: PHASE4
-
"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"
NCT02375217 ·Status: COMPLETED ·Phase: PHASE4
-
Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care
NCT00355368 ·Status: COMPLETED ·Phase: PHASE4
-
Thoracic Neuromodulation for Diabetic Gastroparesis
NCT05273788 ·Status: RECRUITING ·Phase: PHASE1
-
Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium
NCT05718934 ·Status: COMPLETED ·Phase: PHASE4
-
Biological Response of Trauma Patients to Standard Trauma Resuscitation Therapy
NCT01239680 ·Status: COMPLETED ·Phase: NA
-
Pharyngeal Electrical Stimulation for the Treatment of Post-extubation Dysphagia in Acute Stroke
NCT02470078 ·Status: COMPLETED ·Phase: NA
-
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
NCT05795465 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981)
NCT01479764 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers
NCT01640990 ·Status: COMPLETED ·Phase: PHASE1
-
Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels
NCT00671307 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Steroids in Patients With Early ARDS
NCT00562835 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3